Download Adobe Reader Resize font:
Past Clinical Trials
GENERAL INFORMATION ON CLINICAL TRIALS
Consumer Health Forum clinical trials project
The Consumer Health Forum (CHF) was funded by the Department of Innovation, Industry, Science and Research to develop a factsheet to provide consumer-friendly information about clinical trials, in response to a recommendation for improved consumer access to information on clinical trials. CHF members were engaged in focus testing and many provided input into the content and development of the factsheet.
The factsheet is available online, in both colour and print-friendly versions. You can access it on the Consumer Health Forum website: https://www.chf.org.au/clinical-trials-project.php
Please feel free to distribute the link and the factsheet broadly to family, friends and consumer networks.
Clinical Trials Connect
CTC is recognised by the National Health and Medical Research Council (NHMRC) and the Federal Government Department of Innovation Industry Science Research and Tertiary Education (DIISRTE). CTC is also listed as one of two portals most relevant to Australian consumers currently in the Consumer Health Forum 'Guide to Clinical Trials' factsheet, and has recently been listed on the new Government website Australian Clinical Trials.
For more information about Clinical Trials Connect visit the website: www.ctc.asn.au
Australian Clinical Trials
CURRENT CLINICAL TRIALS
Testing the safety, tolerability and efficacy of a new medication called AKP-11 administered to participants with arthritis (19/09/2016)
You are invited to take part in this research project if you have been diagnosed with a form of arthritis and are aged between 18 years and 65 years. This research project is testing the safety, tolerability and efficacy (how well the drug works in alleviating pain) of a new medication called AKP-11, which will be administered to participants with arthritis.
AKP-11 is an experimental topical, anti-inflammatory drug for the treatment of arthritis, including gout. This drug is believed to curb a variety of the pathological events associated with arthritis via a multi-modal mechanism of action. The study seeks to determine the safety, tolerability, and efficacy of topical doses of AKP-11 compared to matching placebo in participants with rheumatoid arthritis or gout.
For further information visit www.anzctr.org.au/ and enter the identifier ACTRN 12616000922471 in the search box and click on the link provided.
Do you have ongoing ankle pain or have you been told you have ankle arthritis? (27/05/2016)
Have you been diagnosed with ankle osteoarthritis?
Do you experience ankle pain and stiffness?
Researchers are seeking volunteers with ankle osteoarthritis to participate in an online survey. To take the survey click here.
We are also currently recruiting for Ankle Osteoarthritis research projects which are held at The University of Queensland. If you are interested in participating in testing of your ankle please visit click here or email
Participate in an Australian-wide study on biologic use in pregnancy (20/05/2016)
This study aims to help other women with rheumatic diseases who would like to have pregnancies in the future.
We are looking at pregnancy outcomes in women with rheumatic diseases exposed to biologics during pregnancy or around the time of conception. This study does not alter your arthritis management in any way.
Can you help us with research looking at pregnancies in women with rheumatic diseases?
If your answer is 'yes' to these questions, you may be able to take part in this study
For further information please contact:
Phone: 0452 423 970
Potential Treatment for Symptoms of Osteoarthritis in the Knee (04/05/2016)
A randomised clinical trial of a treatment for mild to moderate osteoarthritis of the knee.
The study is looking for participants aged between 40 and 80 years of age, with mild OA in either or both knees to test a treatment for 8 weeks.
Trial volunteers would need to:
Clinic locations are in Brisbane and Redcliffe and Sunshine Coast
For further information please contact:
Phone: (07) 3162 0909
Study into shoe inserts for knee cap arthritis (08/04/2016)
If you are aged between 50 and 75 years, and have pain around your knee cap (pain at the front of your knee), you may be eligible to participate in ground breaking research into this common condition.
What will you be asked to do?
All participants will receive a free pair of shoe inserts
For further information, please visit http://semrc.blogs.latrobe.edu.au/kneecap-pain/ or contact Jade on:
Phone: 03 9479 2768
Fast Vs slow weight loss - which is better? The TEMPO Diet Trial (09/02/2016)
Losing excess weight is scientifically proven to help reduce and prevent joint pain. One way to get support for weight loss is to participate in a clinical weight loss trial, where you get the support of a research team and others in the trial.
For many years health professionals have recommended ‘slow and steady’ weight losses of approximately 0.1 to 1 kilo per week. In recent years however, an increasing number of health professionals are prescribing meal replacement diets called very low calorie diets (VLCDs) because they can induce relatively fast weight losses of approximately 0.5 to 2 kilos per week, which some people find motivating, and because some people report not feeling hungry while following a VLCD.
While VLCDs are known to be safe and effective in the short-term (for up to one year), the long-term consequences are unknown. This study will demonstrate whether or not there is any difference between the effects of weight loss via VLCD or conventional diet on metabolic health, body fat content and distribution, muscle mass and strength, and bone density in post-menopausal women for 3 years after commencement of the diet.
To watch Associate Professor Amanda Salis talking about the TEMPO Diet Trial click here.
To watch Associate Professor Amanda Salis talking about A Day in the Life on a VLCD, click here.
To read the Information for Participants click here (PDF file).
Recruitment for the TEMPO Diet Trial is currently underway. If you are interested in participating in this trial and are female, living in the Sydney metropolitan area, aged 45-65, postmenopausal for 5 years or more, are non-diabetic and you have a body mass index (BMI*) of 30 to 40 kg/m2, you may be eligible for this study.
*To calculate your BMI, divide your weight in kilograms by the square of your height in meters, or use this web-based BMI calculator: http://www.heartfoundation.org.au/healthy-eating/Pages/bmi-calculator.aspx.
What osteoarthritis treatment is best for you? (06/11/2015)
If you have knee and/or hip osteoarthritis (OA), the process of deciding on a treatment can be difficult.
The University of Sydney is conducting reserach to see what helps people with hip or knee OA by conducting a research project on decision aids.
A 'decision aid' is a tool to help you understand what your treatment options are and what is important to you in deciding among the various options.
The main purpose of this study is to evaluate the usefulness of the decision aid for people with osteoarthritis and to see if there is a change in the quality of decisions after using having used it.
Read more and do the survey here: http://healthbook.health.usyd.edu.au/index.php?PageID=survey_respond&SurveyID=1143
Allow about 30 minutes to complete the survey and to find out what OA treatments are best for you.
CUBA – Cane for Knee Pain Study (02/11/2015)
Then the CUBA – Cane for Knee Pain Study may be for you. The University of Melbourne (Parkville) and Royal North Shore Hospital Sydney (St Leonards) are investigating the effect of daily walking with a cane for 12 weeks on knee osteoarthritis, pain and physical function.
If you are interested in participating or would like more information, please visit the study website http://cubastudy.info or contact Charlotte on:
Phone: 03 8344 0485
Do you suffer from fibromyalgia? (22/7/15)
The Monash Alfred Psychiatry Research Centre (MAPrc) at the Alfred Hospital campus is currently seeking volunteers for a clinical trial of a non-medication investigational treatment for fibromyalgia called repetitive Transcranial Magnetic Stimulation (rTMS).
rTMS is a painless, safe, and non-invasive means of stimulating nerve cells in the brain. We are conducting this study to see whether we can reduce the symptoms associated with fibromyalgia.
Participants should be located in Melbourne and be:
Participation will involve attending MAPrc for 20 rTMS treatments over a four week period. Each treatment takes approximately 30 minutes.
For more information click here or contact Dr Bernadette Fitzgibbon:
Phone: 03 9076 9860
STEP Trial - Safety, Tolerability and Efficacy of Progenza for osteoarthritis (21/7/15)
The STEP trial is a randomised phase 1 clinical trial, investigating the safety and efficacy of a stem cell therapy (Progenza) for knee osteoarthritis. It will compare stem cells to placebo, looking at safety, pain, function and cartilage loss in participants.
Study participants need to be located in Sydney and be:
For more information click here or contact Carolyn:
Phone: 0434 292 110
Melbourne - Knee Osteoarthritis Pain study (17/7/2015)
This study is a randomised clinical trial, investigating a new medication for knee pain in adults with osteoarthritis. We will compare amitriptyline 25mg tablets with a placebo, looking at knee-pain and its effect on daily life over a 12-week period. If effective, this medication will offer a new way to manage pain for people with knee osteoarthritis.
Participants should be located in Melbourne and be:
For more information contact Cameron, Molly, or Clare:
Phone: 03 9903 0553
Reviewed and updated August 2016